MediSwipe Inc. Brings "High Expectations" to Seattle Hempfest as Company Receives Purchase Order for Over 10,000 Units of Chillo Hemp Beverage for Historic Weekend Event
MediSwipe Inc. Brings "High Expectations" to Seattle Hempfest as Company Receives Purchase Order for Over 10,000 Units of Chillo Hemp Beverage for Historic Weekend Event
LOS ANGELES, CA--(Marketwired - August 16, 2013) - MediSwipe Inc. (www.MediSwipe.com) (OTCQB: MWIP), the leader in Compassionate Care Technology Solutions for the medicinal marijuana industry, today announced that the Company has received a purchase order through its' Washington state distributor for over 10,000 units of "Chillo," the Company's Hemp based energy drink. The drinks will be sold for the first time at the historic event through multiple vendor stands at Seattle's Hempfest this weekend.
The Seattle Hempfest is the world's largest event advocating cannabis law reform, in a unique "protestival" environment. This annual event is held every August in Myrtle Edwards Park on the Seattle waterfront and expected to attract over 200,000 marijuana enthusiasts. It is anticipated to span two miles of waterfront Seattle parks on Friday, Saturday and Sunday. The event will feature 117 musical acts on six stages and more than 100 speakers, not to mention 400 vendors offering informational pamphlets, merchandise, food and art.
"The Seattle Hempfest is probably the most important branding opportunity we have had to date to introduce our brand Chillo to the mass market over a few days. With several hundred thousand people in attendance and a much targeted audience, we expect Chillo sales and awareness to have a dramatic increase. Our people will be there on the ground carrying out our marketing campaign, selling drinks, giving away shirts and increasing our market share within the billion dollar energy drink market," stated B. Michael Friedman, CEO for MediSwipe Inc.
The Company recently announced that it has signed an exclusive license and formed a joint alliance with The Medical Cannabis Network to operate, market and administrate the premiere online physician and patient registry www.MarijuanaDoctors.com. This is the largest online portal and registry for medicinal marijuana patients and physicians in the US. MediSwipe shall receive monthly residual fees for every doctor, dispensary and caregiver registered with the site. Several hundred are already registered. The license also covers major online portals with MediSwipe as the exclusive marketer for www.Potlocator.com, www.StrainBrain.com and others. MediSwipe shall additionally receive advertising fees for run of the sites, coupons, and premium listings on the portal site network. A special section on each portal is now offered for the MediSwipe products including "Chillo" in which over 2,500 registered dispensaries and caregivers throughout 20 states in legal jurisdictions may order the products directly from the network.
About MediSwipe Inc.
MediSwipe Inc. (www.MediSwipe.com) provides innovative patient solutions for electronically processing transactions within the healthcare industry. MediSwipe provides terminal-based service packages and an integrated Web Portal add-ons for physicians, clinics, hospitals and medical dispensaries that include: digital patient records, Electronic Referrals, Credit/Debit Card merchant services, Check Guarantee and Accounts.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of MediSwipe Inc. to be materially different from the statements made herein.